Amyris (AMRS) Misses Q3 EPS by 42c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
AMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
November 8, 2022 4:05 PM ESTSixth consecutive quarter of record consumer revenue Consumer revenue of $46.6 million increased 98% compared to Q3 2021Record core revenue of $71.1 million grew 49% compared to the prior year quarter"Fit to Win" revenue, cost and cash actions deliver $10 million in Q3$180 million of new funding closed - strategic transaction on track to self-fund growth
EMERYVILLE, Calif., Nov. 8, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market technology platform and clean beauty consumer brands, today announced financial results for the... More
